Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.566

-1.4%

1:06 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	2/5/2009 3:10:11 PM
	of 368

Sangamo BioSciences-SGMO is advancing its early-stage pipeline, says Cantor After Sangamo reported higher than expected Q4 EPS, Cantor Fitzgerald believes demand for the company's technology will increase. The firm maintains a Buy rating on the shares. Rec-Upgrade story about SGMO from Merriman Merriman upgraded shares as they expect news flow to drive shares in 2009. :t

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next